Recurrent transplant renal vein thrombosis caused by May-Thurner syndrome: a case report and review of literature Authors: Koosha kamali, Hossein Saffari, Ehsan Zolfi, Shervin Najafizadeh, Nasrollah Abian, Farhad Ahmadi, Vahid Vahedisoraki Published: 2026 ABSTRACT Transplant renal vein thrombosis (TRVT) affects 0.1% to 4.2% of transplants, leading to graft loss in almost all cases. Mechanical factors are the most common underlying cause of TRVT, a category that includes May-Thurner syndrome (MTS). We report a 62-year-old man underwent left-sided kidney transplantation but developed recurrent deep vein thrombosis and TRVT. Two emergency thrombectomies restored graft function, though no iatrogenic cause was identified. Further investigations revealed MTS as the underlying etiology. Left common iliac vein stenting with long-term anticoagulation was implemented, highlighting the importance of considering anatomic venous anomalies in transplant recipients with unexplained or recurrent thrombosis. Introduction May–Thurner syndrome (MTS) is characterized by compression of the iliocaval venous segment against the underlying vertebral body by the overlying arterial system, most commonly involving the left common iliac vein (LCIV). Although asymptomatic in most individuals, MTS can impair venous outflow and predispose patients to deep vein thrombosis (DVT).1 Transplant renal vein thrombosis (TRVT), which affects 0.1%–4.2% of kidney transplant recipients, occurs predominantly within the first 2 weeks after transplantation surgery2,3 and results in graft loss in most cases.2 Mechanical factors, including external compression of the venous system, are considered the most common contributors to TRVT.2,4 Therefore, May-Thurner syndrome (MTS) may predispose patients undergoing left-sided kidney transplantation to TRVT. However, reports of TRVT secondary to MTS in the English-language literature remain scarce. Here, we report a rare case of recurrent TRVT due to MTS and discuss its clinical presentation, diagnostic challenges, and management. We also provide a literature review in this regard. Case presentation A 62-year-old man with autosomal dominant polycystic kidney disease who was on hemodialysis for 2 years and had left nephrectomy one year prior due to severe flank pain, underwent living donor kidney transplantation on the left side of the pelvis. The transplant renal vein (TRV) and artery were anastomosed end-to-side to the left external iliac vein (LEIV) and artery, respectively. Immediate postoperative Doppler ultrasonography (DUS) showed good blood flow. Urine output was 700 mL/hour on the surgery day. Immunosuppressive medications included tacrolimus and prednisolone. By postoperative day (POD) 4, his serum creatinine decreased to 1.3 mg/dL. On the morning of POD 5, the patient developed left leg swelling. DUS revealed left lower extremity DVT extending to the femoral vein sparing LEIV and TRV. Heparin infusion (1100 units/hour) was started. As the patient complained of surgical site bulging and pain, abdominopelvic CT scan was taken which showed no significant hematoma nor lymphocele. Urine output remained ∼250 mL/h but later that night he became anuric. Repeat DUS showed thrombus progression to the LEIV, TRVT, and severe reduction in transplant renal artery blood flow. Creatinine rose to 3.2 mg/dL. Urgent surgical exploration revealed a congested graft with palpable thrombosis in the TRV and LEIV. Incising the LEIV proximal to the anastomosis, thrombi burst out. The graft color normalized and no anastomotic stenosis was detected. The incision was sutured and intraoperative DUS confirmed restored blood flow. Heparin was continued postoperatively. The patient's urine output improved, leg swelling resolved, and creatinine returned to 1.4 mg/dL after 24 hours. 2 days later, apixaban 5 mg twice daily replaced heparin. The following day was uneventful. However, on the next day, the patient again developed leg swelling, anuria, and increased creatinine (2.3 mg/dL). DUS confirmed recurrent leg thrombosis extending to LEIV and TRV. A second open thrombectomy was performed. Both heparin and apixaban were continued afterward. Creatinine normalized after 3 days, and follow-up DUS showed no thrombosis. The patient remained hospitalized for further investigations. Reviewing our case in a multidisciplinary meeting with the presence of transplant surgery team, nephrologist, vascular surgeon, and radiologist, the compression of the LCIV by the left common iliac artery could be inferred from the CT scan (Fig. 1a and b) which suggested the possibility of MTS. Hence, CT venography by injecting contrast into the left femoral vein was proposed for the patient showing contrast in the collateral thigh and pelvic veins evading LEIV, corroborating high pressure in left iliac veins (Fig. 1c); further confirming presence of MTS. Therefore, balloon dilatation and stenting of the LCIV were planned on the same admission session.Fig. 1a. Abdominopelvic CT scan without contrast showing inferior vena cava (blue arrow) and aorta (red arrow). b. Abdominopelvic CT scan without contrast indicating right and left common iliac arteries (marked by red color), right common iliac vein (marked by blue color), and left common iliac vein (marked by blue color and white outline). The compression of left common iliac vein by left common iliac artery is evident (blue arrow). The transplanted kidney and the drain can be seen in the image (yellow arrow). c. Pelvic CT venography revealing contrast entrance into small veins as collateral veins after injection of contrast into left femoral vein (green arrow). a. Abdominopelvic CT scan without contrast showing inferior vena cava (blue arrow) and aorta (red arrow). b. Abdominopelvic CT scan without contrast indicating right and left common iliac arteries (marked by red color), right common iliac vein (marked by blue color), and left common iliac vein (marked by blue color and white outline). The compression of left common iliac vein by left common iliac artery is evident (blue arrow). The transplanted kidney and the drain can be seen in the image (yellow arrow). c. Pelvic CT venography revealing contrast entrance into small veins as collateral veins after injection of contrast into left femoral vein (green arrow). During the intervention, the left femoral vein access was obtained. Venography confirmed LCIV stenosis and dilated collateral veins (Fig. 2a). Balloon angioplasty was performed by balloon dilatation catheter (Atlas™16mm-40mm). Then, iliac vein stent (Venovo™18mm-120mm) was deployed from iliocaval confluence to LEIV proximal to the anastomosis. Post-deployment dilatation was completed and subsequent venography showed normal contrast flow into the LCIV and inferior vena cava, with near resolution of collateral veins (Fig. 2b and c).Fig. 2a. Venography revealed left common iliac vein stenosis by relatively less contrast entering it (dark blue arrow) and more contrast entering collateral veins (light blue arrows) after injection from left femoral vein. White arrow depicts the location of graft vein anastomosis. b. Contrast passage from left femoral vein to left external iliac vein and left common iliac vein after deployment of venous stent. c. Contrast was washed away from left external iliac vein and left common iliac vein into inferior vena cava without entering collateral veins after deployment of venous stent. a. Venography revealed left common iliac vein stenosis by relatively less contrast entering it (dark blue arrow) and more contrast entering collateral veins (light blue arrows) after injection from left femoral vein. White arrow depicts the location of graft vein anastomosis. b. Contrast passage from left femoral vein to left external iliac vein and left common iliac vein after deployment of venous stent. c. Contrast was washed away from left external iliac vein and left common iliac vein into inferior vena cava without entering collateral veins after deployment of venous stent. The patient was discharged 6 days after venous stenting on apixaban having creatinine of 1.4 mg/dL. 4 months later, he remained symptom-free with normal graft function (creatinine 1.3 mg/dL) and no recurrence of DVT or TRVT. Discussion MTS was first described in 1957 as a cause of pelvic vein thrombosis.5 A decade later, Cockett and Thomas established its connection to ipsilateral iliofemoral DVT.6 The exact prevalence of MTS in general population remains unclear as MTS is often asymptomatic.7 It is clinically linked to 2 to 5% of all DVT cases; however, MTS may have a more significant role given the disproportionately higher incidence of left-sided DVT.8 TRVT presents acutely with symptoms such as oliguria, deteriorating graft function, and painful graft, which in severe cases may lead to its rupture.3 Among numerous risk factors for TRVT, mechanical causes, including venous compression, are considered significant contributors2,3,7; and as MTS is a form of venous compression, it should be recognized as an important risk factor for TRVT. In Table 1 we categorized all possible risk factors for TRVT.2,3,7Table 1Risk factors of transplant renal vein thrombosis.Table 1CategoryRisk FactorsMechanisms/NotesDonor-relatedUse of right kidneyShorter renal vein (prone to compression)Multiple graft vesselsAssociated in some studies, disputed in othersProlonged ischemic timeEndothelial thrombogenicity, Decreased perfusion due to acute tubular necrosis may cause thrombosisVascular injuriesEndothelial damage increases thrombosis riskOlder donor ageAtherosclerotic vesselsRecipient-relatedAtherosclerosis (esp. in older recipients)Atherosclerotic vessels predisposes to thrombosisVessel size mismatch (esp. in pediatric patients)Small recipient vessels predispose to thrombosisPre-transplant dialysis modalityPeritoneal dialysis increases plasma procoagulant factorsHypercoagulable statesAntiphospholipid antibody syndrome, antithrombin deficiency, Factor V Leiden mutation, prothrombin gene mutationPerioperative hemodynamic instabilityHypotension or dehydration may induce hypoperfusion of kidney and thrombosisPrimary renal diseaseMembranous nephropathy links with higher risk of venous graft thrombosisInadequate recipient's venous flowStenosis of iliac vein such as May-Thurner syndromeExtension of pre-existing deep vein thrombosisMay propagate into graft veinTechnical (operative)Kinking of graft veinLong renal veinMore prone to compressionAnastomotic stenosisNarrowing predisposes to clot formationEndothelial injury during surgical manipulationCompressionHematomas, lymphoceles, or renal artery compression (esp. contralateral transplants)Immunosuppression-relatedCalcineurin inhibitors (general)Promote hypofibrinolysis via enhancing plasminogen activator inhibitor expressionCD3 Monoclonal AntibodyHigh-dose methylprednisolone pulsesAntithymocyte/antilymphocyte globulin Table 1Risk factors of transplant renal vein thrombosis.Table 1CategoryRisk FactorsMechanisms/NotesDonor-relatedUse of right kidneyShorter renal vein (prone to compression)Multiple graft vesselsAssociated in some studies, disputed in othersProlonged ischemic timeEndothelial thrombogenicity, Decreased perfusion due to acute tubular necrosis may cause thrombosisVascular injuriesEndothelial damage increases thrombosis riskOlder donor ageAtherosclerotic vesselsRecipient-relatedAtherosclerosis (esp. in older recipients)Atherosclerotic vessels predisposes to thrombosisVessel size mismatch (esp. in pediatric patients)Small recipient vessels predispose to thrombosisPre-transplant dialysis modalityPeritoneal dialysis increases plasma procoagulant factorsHypercoagulable statesAntiphospholipid antibody syndrome, antithrombin deficiency, Factor V Leiden mutation, prothrombin gene mutationPerioperative hemodynamic instabilityHypotension or dehydration may induce hypoperfusion of kidney and thrombosisPrimary renal diseaseMembranous nephropathy links with higher risk of venous graft thrombosisInadequate recipient's venous flowStenosis of iliac vein such as May-Thurner syndromeExtension of pre-existing deep vein thrombosisMay propagate into graft veinTechnical (operative)Kinking of graft veinLong renal veinMore prone to compressionAnastomotic stenosisNarrowing predisposes to clot formationEndothelial injury during surgical manipulationCompressionHematomas, lymphoceles, or renal artery compression (esp. contralateral transplants)Immunosuppression-relatedCalcineurin inhibitors (general)Promote hypofibrinolysis via enhancing plasminogen activator inhibitor expressionCD3 Monoclonal AntibodyHigh-dose methylprednisolone pulsesAntithymocyte/antilymphocyte globulin Risk factors of transplant renal vein thrombosis. Ultrasonography is the first-line imaging modality for diagnosing TRVT. Gray-scale ultrasonography may show cortical edema, perirenal hematoma, and TRV thrombosis. DUS can detect venous obstruction signs namely reversed arterial diastolic flow, a spike-like systolic wave, and absence of renal vein visualization.2 Advanced imaging such as CT angiography (CTA) offers superior anatomical detail and can identify rare anomalies like MTS. Although conventional angiography remains the gold standard for vascular diagnosis, its invasiveness and risk of nephrotoxicity restrict its use to patients planned for endovascular interventions.2,3 We summarized cases of MTS affecting transplanted kidney in Table 2. Among these cases, four were successfully managed with endovascular balloon dilation and stenting. One case, however, underwent graftectomy due to severe graft damage. What makes our case special is the recurrence of DVT and TRVT despite anticoagulation therapy, necessitating thrombectomy twice. Such phenomenon combined with the fact that proximal extension of an iliofemoral DVT is not expected due to the high volume of blood entering the iliac vein from the graft,9 guided us to look for an underlying pathology found to be MTS which was, subsequently, treated with balloon dilatation and LCIV and LEIV stenting.Table 2Review of all cases of May-Thurner syndrome affecting transplanted kidney in English literature.Table 2Author (year)Age, Sex, Past medical historyLiving vs Deceased donor kidneySideIliac vessels used for anastomosisAnticoagulant after surgeryImmunosuppressionInterval from surgery to disease presentationFinal diagnosisTRVTLeft lower extremity edema or DVTTreatmentFinal Cr level/other outcomeArrazola et al. (2001)763 years, Male, DM, HTN, CAD, PVDLivingLeftLEIA and LEIVlow-dose heparin drip (200 units/hour)antibody induction plus MMF, tacrolimus, and prednisone2 days2 different areas of iliac vein compression: 1) LEIV by hematoma 2) LCIV due to MTSNoNoDeploying 2 stents: one in LEIV and the other one in LCIV1.9 mg/dL on discharge day (10 days after procedure)Campsen et al. (2010)1157 years, FemaleLivingLeftNot specified-N/A13 daysFixed stenosis at the origin of the LCIVYesYesThrombectomy with balloon maceration, deploying iliac vein stent1.3 mg/dL on discharge day (3 days after procedure)Vaidya et al. (2012)1268 years, Female, ADPKDDeceasedLeftNot specified-tacrolimus and prednisone4 monthsLCIV compression by right iliac arteryYesNoThrombolysis, Angioplasty and deploying iliac vein stent0.8 mg/dL after 1 yearKonopa et al. (2024)363 years, MaleDeceasedLeftLEIA and LEIVLow molecular weight heparinMMF, tacrolimus, and prednisone4 daysNarrowed LCIV due to MTSYesNoGraftectomySecond kidney transplant surgery on right side 18 months laterOnuigbo et al. (2025)1343 years, Male, ADPKDDeceasedLeftNot specified-N/A2 monthsNarrowed LEIV compressed by native ADPKD kidneyNoNoopen left native nephrectomy2.0 mg/dLKamali et al. (2025)-current case62 years, Male, ADPKDLivingLeftLEIA and LEIV-tacrolimus and prednisone5 daysLCIV compression by right iliac arteryYesYesOpen thrombectomy (twice), LCIV balloon dilation with deploying stent into LCIV and LEIV1.3 mg/dL four months after surgeryAbbreviations: ADPKD, autosomal dominant polycystic kidney disease; CAD, coronary artery disease; Cr, creatinine; DVT, deep vein thrombosis; DM, diabetes mellitus; DUS, Doppler ultrasonography; HTN, hypertension; LCIV, left common iliac vein; LEIA, left external iliac artery; LEIV, left external iliac vein; MRA, magnetic resonance angiography; MTS, May-Thurner syndrome; MDM, multidisciplinary meeting; MMF, Mycophenolate mofetil; N/A, not available; PVD, peripheral vascular disease; POD, post-operation day; TRV, transplant renal vein; TRVT, transplant renal vein thrombosis; U/O, urine output. Table 2Review of all cases of May-Thurner syndrome affecting transplanted kidney in English literature.Table 2Author (year)Age, Sex, Past medical historyLiving vs Deceased donor kidneySideIliac vessels used for anastomosisAnticoagulant after surgeryImmunosuppressionInterval from surgery to disease presentationFinal diagnosisTRVTLeft lower extremity edema or DVTTreatmentFinal Cr level/other outcomeArrazola et al. (2001)763 years, Male, DM, HTN, CAD, PVDLivingLeftLEIA and LEIVlow-dose heparin drip (200 units/hour)antibody induction plus MMF, tacrolimus, and prednisone2 days2 different areas of iliac vein compression: 1) LEIV by hematoma 2) LCIV due to MTSNoNoDeploying 2 stents: one in LEIV and the other one in LCIV1.9 mg/dL on discharge day (10 days after procedure)Campsen et al. (2010)1157 years, FemaleLivingLeftNot specified-N/A13 daysFixed stenosis at the origin of the LCIVYesYesThrombectomy with balloon maceration, deploying iliac vein stent1.3 mg/dL on discharge day (3 days after procedure)Vaidya et al. (2012)1268 years, Female, ADPKDDeceasedLeftNot specified-tacrolimus and prednisone4 monthsLCIV compression by right iliac arteryYesNoThrombolysis, Angioplasty and deploying iliac vein stent0.8 mg/dL after 1 yearKonopa et al. (2024)363 years, MaleDeceasedLeftLEIA and LEIVLow molecular weight heparinMMF, tacrolimus, and prednisone4 daysNarrowed LCIV due to MTSYesNoGraftectomySecond kidney transplant surgery on right side 18 months laterOnuigbo et al. (2025)1343 years, Male, ADPKDDeceasedLeftNot specified-N/A2 monthsNarrowed LEIV compressed by native ADPKD kidneyNoNoopen left native nephrectomy2.0 mg/dLKamali et al. (2025)-current case62 years, Male, ADPKDLivingLeftLEIA and LEIV-tacrolimus and prednisone5 daysLCIV compression by right iliac arteryYesYesOpen thrombectomy (twice), LCIV balloon dilation with deploying stent into LCIV and LEIV1.3 mg/dL four months after surgeryAbbreviations: ADPKD, autosomal dominant polycystic kidney disease; CAD, coronary artery disease; Cr, creatinine; DVT, deep vein thrombosis; DM, diabetes mellitus; DUS, Doppler ultrasonography; HTN, hypertension; LCIV, left common iliac vein; LEIA, left external iliac artery; LEIV, left external iliac vein; MRA, magnetic resonance angiography; MTS, May-Thurner syndrome; MDM, multidisciplinary meeting; MMF, Mycophenolate mofetil; N/A, not available; PVD, peripheral vascular disease; POD, post-operation day; TRV, transplant renal vein; TRVT, transplant renal vein thrombosis; U/O, urine output. Review of all cases of May-Thurner syndrome affecting transplanted kidney in English literature. Abbreviations: ADPKD, autosomal dominant polycystic kidney disease; CAD, coronary artery disease; Cr, creatinine; DVT, deep vein thrombosis; DM, diabetes mellitus; DUS, Doppler ultrasonography; HTN, hypertension; LCIV, left common iliac vein; LEIA, left external iliac artery; LEIV, left external iliac vein; MRA, magnetic resonance angiography; MTS, May-Thurner syndrome; MDM, multidisciplinary meeting; MMF, Mycophenolate mofetil; N/A, not available; PVD, peripheral vascular disease; POD, post-operation day; TRV, transplant renal vein; TRVT, transplant renal vein thrombosis; U/O, urine output. As Table 2 depicts, endovascular treatment including balloon dilatation and stenting (with thrombectomy or thrombolysis whenever needed) seems to be a promising approach for managing MTS-related TRVT. Our unique experience in this patient confirms that urgent thrombectomies can save transplanted kidney before stent placement, but it is the balloon dilation and stenting which ultimately prevents recurrent thrombosis. There is currently no literature supporting prophylactic stent placement in transplant candidates with MTS.10 However, given the potential “one too many” complication, i.e. graft loss, prophylactic stenting may be a reasonable strategy. Future studies may provide insight regarding the prophylactic role of such intervention in MTS patients undergoing left side kidney transplantation. Conclusion TRVT, especially recurrent one, may be secondary to unrecognized venous anomalies such as MTS. In such cases, early diagnosis and correction with thrombectomy plus iliac vein stenting can preserve graft function and prevent TRVT recurrence. CRediT authorship contribution statement Koosha kamali: Supervision, Methodology, Conceptualization. Hossein Saffari: Validation, Data curation. Ehsan Zolfi: Visualization, Investigation. Shervin Najafizadeh: Writing – review & editing, Supervision. Nasrollah Abian: Writing – original draft, Validation, Software, Investigation. Farhad Ahmadi: Investigation, Data curation. Vahid Vahedisoraki: Writing – review & editing, Investigation. Funding sources This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.